The mycosis fungoides market is projected to experience consistent growth from 2025 to 2034, fueled by increasing disease awareness, earlier detection, and the availability of established treatment ...

For some patients with the most common type of lung cancer, known as lung adenocarcinoma, there's new hope. In a new study ...

Former Alabama football player Bennett Whisenhunt beat cancer using lessons learned as a walk-on. How he survived Hodgkin's ...

The FDA approved epcoritamab-bysp in combination with lenalidomide and rituximab for patients with relapsed or refractory ...

In this three-part webinar series, we invite you to explore the benefits of a standardized workflow in leukemia and lymphoma analysis. Join this showcase of Beckman Coulter’s new DxFLEX flow cytometer ...

BPDCN is an aggressive type of blood cancer that originates from plasmacytoid dendritic cells (pDCs), a component of the immune system that produces type 1 interferon cytokines. These cytokines help ...

In this three-part webinar series, we invite you to explore the benefits of a standardized workflow in leukemia and lymphoma analysis. Join this showcase of Beckman Coulter’s new DxFLEX flow cytometer ...

Hematopoietic and lymphocytic neoplasms (HLNs) are a diverse group of malignancies affecting blood and lymphatic systems, with outcomes varying from manageable conditions to fatal diseases.

(a) Peripheral blood smear in a patient with the chronic phase of chronic myeloid leukemia (CML) before treatment; (b) Detection of BCR::ABL1 fusion gene, p210 by RNA sequencing; (c) Peripheral blood ...

Patients with TP53/PPM1D mutations in their stem cell product had an increased risk of myeloid neoplasms in patients with Hodgkin lymphoma undergoing autologous stem cell transplant. While autologous ...

Department of Population Health Sciences, George Davies Centre, University of Leicester, Leicester LE1 7RH, UK In The Lancet Oncology, Milena Sant and colleagues 8 focus on the long-term survival of ...